Articles from Mosaic Clinical Technologies

Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2.

Mosaic Clinical Technologies™ (Mosaic), the technology and AI services division of Radiology Partners (RP), today announced the appointment of Mike Peresie as President of Mosaic. Mike joins Mosaic as a seasoned digital health executive with more than two decades of experience leading high-growth innovation portfolios and scaled software, network and data businesses. He brings deep expertise in building technology platforms that improve access, quality and affordability across healthcare.

Amid an acute and worsening global shortage of radiologists, driven by rising imaging demand, limited residency growth and accelerated workforce attrition, Mosaic Clinical Technologies™ (Mosaic), the technology and AI services division of Radiology Partners (RP), announced the acquisition of Cognita Imaging Inc. Cognita is a pioneer in vision language models purpose-built for radiology. The combination brings together Mosaic’s enterprise-scale operating system, MosaicOS™, and Cognita’s cutting edge AI technology and expertise to accelerate development of next-generation tools that expand clinical capacity, improve diagnostic accuracy and enhance patient care.